<DOC>
	<DOCNO>NCT00163358</DOCNO>
	<brief_summary>The aim study compare efficacy ciclesonide versus fix combination fluticasone propionate/salmeterol versus placebo , long-term asthma control patient mild persistent asthma . The study duration consist baseline period ( 2 week ) treatment period ( 12 month ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Ciclesonide vs Fixed Combination Fluticasone Propionate/Salmeterol v Placebo Patients With Mild Persistent Asthma ( 12 75 ) ( BY9010/M1-132 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Main Clinical diagnosis mild persistent asthma Pretreatment SABAs FEV1 ≥80 % predict Good health exception asthma Main Concomitant severe disease disease contraindication use inhaled steroid COPD ( chronic bronchitis emphysema ) and/or relevant lung disease cause alternate impairment pulmonary function Pregnancy Intention become pregnant course study Breast feeding Lack safe contraception Current smoker ≥10 packyears exsmokers ≥10 packyears</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Fluticasone propionate</keyword>
	<keyword>Salmeterol</keyword>
</DOC>